◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › C › COO

The Cooper Companies, Inc (COO) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Health Care Supplies · DATA UPDATED 2026-09-19

The Cooper Companies, Inc (COO) operates in the Health Care Supplies industry and is headquartered in San Ramon, United States with about 15,000 employees. Its market capitalization is roughly $11 billion. In the fiscal year ended 2025-10-31, COO reported $4.1B in revenue and $375M in net income.

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical.

Interactive charts & full statements → Open the COO valuation workbench →

COO Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-07-31	2025-10-31	2024-10-31	2023-10-31	2022-10-31	2021-10-31	2020-10-31	2019-10-31	2018-10-31	2017-10-31	2016-10-31	2015-10-31	2014-10-31	2013-10-31	2012-10-31	2011-10-31	2010-10-31	2009-10-31	2008-10-31	2007-10-31	2006-10-31
Total Revenue	$4.2B	$4.1B	$3.9B	$3.6B	$3.3B	$2.9B	$2.4B	$2.7B	$2.5B	$2.1B	$2.0B	$1.8B	$1.7B	$1.6B	$1.4B	$1.3B	$1.2B	$1.1B	$1.1B	$951M	$859M
Gross Profit	$2.7B	$2.5B	$2.6B	$2.4B	$2.1B	$2.0B	$1.5B	$1.8B	$1.6B	$1.4B	$1.2B	$1.1B	$1.1B	$1.0B	$924M	$805M	$677M	$596M	$610M	$520M	$526M
Gross Margin %	64.7%	60.7%	66.6%	65.6%	64.7%	66.9%	63.1%	66.2%	64.5%	63.8%	59.6%	59.6%	63.5%	64.7%	63.9%	60.5%	58.4%	55.2%	57.4%	54.6%	61.2%
Operating Income (EBIT)	$544M	$683M	$706M	$533M	$508M	$506M	$312M	$547M	$403M	$429M	$324M	$237M	$306M	$306M	$283M	$228M	$190M	$150M	$127M	$46M	$113M
Operating Margin %	12.8%	16.7%	18.1%	14.8%	15.3%	17.3%	12.8%	20.6%	15.9%	20.1%	16.5%	13.2%	17.8%	19.3%	19.6%	17.1%	16.4%	13.9%	11.9%	4.8%	13.1%
Net Income	$571M	$375M	$392M	$294M	$386M	$2.9B	$238M	$467M	$140M	$373M	$274M	$204M	$270M	$296M	$248M	$175M	$113M	$101M	$65M	($11M)	$66M
Net Margin %	13.5%	9.2%	10.1%	8.2%	11.7%	100.8%	9.8%	17.6%	5.5%	17.4%	13.9%	11.3%	15.7%	18.6%	17.2%	13.2%	9.7%	9.3%	6.2%	-1.2%	7.7%
EBITDA	—	$1.1B	$1.1B	$886M	$879M	$824M	$590M	$826M	$690M	$616M	$520M	$425M	$443M	$447M	$398M	$308M	$255M	$252M	$209M	$140M	$181M
Earnings Per Share (EPS)	$2.93	$1.87	$1.96	$1.48	$1.94	$14.77	$1.20	$2.33	$0.70	$1.88	$1.40	$1.03	$1.38	$1.49	$1.26	$0.91	$0.61	$0.55	$0.35	$-0.06	$0.35
Shares Outstanding (M)	—	200M	200M	199M	199M	199M	198M	200M	199M	198M	196M	197M	196M	199M	197M	193M	186M	182M	187M	179M	190M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

COO Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-07-31	2026-04-30	2026-01-31	2025-10-31	2025-07-31	2025-04-30	2025-01-31	2024-10-31	2024-07-31
Total Revenue	$1.1B	$1.1B	$1.0B	$1.1B	$1.1B	$1.0B	$965M	$1.0B	$1.0B
Gross Profit	$712M	$735M	$695M	$601M	$692M	$679M	$660M	$678M	$663M
Gross Margin %	66.8%	68.0%	67.9%	56.4%	65.3%	67.8%	68.4%	66.5%	66.1%
Operating Income (EBIT)	$222M	($31M)	$213M	$140M	$176M	$185M	$182M	$198M	$192M
Operating Margin %	20.8%	-2.9%	20.8%	13.2%	16.6%	18.4%	18.9%	19.5%	19.2%
Net Income	$433M	($78M)	$131M	$85M	$98M	$88M	$104M	$118M	$105M
Net Margin %	40.6%	-7.2%	12.8%	7.9%	9.3%	8.8%	10.8%	11.5%	10.4%
EBITDA	—	$68M	$310M	$215M	$273M	$261M	$270M	$287M	$281M
Earnings Per Share (EPS)	$2.24	$-0.40	$0.66	$0.43	$0.49	$0.44	$0.52	$0.58	$0.52
Shares Outstanding (M)	—	195M	197M	198M	201M	201M	201M	201M	201M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

COO Free Cash Flow History

Cash flow	TTM → 2026-07-31	2025-10-31	2024-10-31	2023-10-31	2022-10-31	2021-10-31	2020-10-31	2019-10-31	2018-10-31	2017-10-31	2016-10-31	2015-10-31	2014-10-31	2013-10-31	2012-10-31	2011-10-31	2010-10-31	2009-10-31	2008-10-31	2007-10-31	2006-10-31
Cash from Operations (CFO)	$1.0B	$796M	$709M	$608M	$692M	$739M	$487M	$713M	$669M	$594M	$510M	$391M	$455M	$416M	$315M	$336M	$268M	$223M	$97M	$134M	$163M
Capital Expenditures (CapEx)	$355M	$362M	$421M	$392M	$242M	$214M	$310M	$292M	$194M	$127M	$153M	$243M	$238M	$178M	$100M	$104M	$74M	$94M	$125M	$184M	$155M
Free Cash Flow (FCF)	$678M	$434M	$288M	$215M	$450M	$524M	$176M	$421M	$475M	$466M	$357M	$148M	$217M	$238M	$215M	$233M	$194M	$129M	($28M)	($50M)	$8M
FCF Margin %	16.0%	10.6%	7.4%	6.0%	13.6%	17.9%	7.2%	15.9%	18.8%	21.8%	18.1%	8.2%	12.6%	15.0%	14.9%	17.5%	16.7%	12.0%	-2.7%	-5.2%	0.9%
Dividends Paid	—	$0M	$0M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

COO Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-07-31	2026-04-30	2026-01-31	2025-10-31	2025-07-31	2025-04-30	2025-01-31	2024-10-31	2024-07-31
Cash from Operations (CFO)	$342M	$183M	$261M	$248M	$261M	$96M	$191M	$268M	$208M
Capital Expenditures (CapEx)	$69M	$86M	$102M	$98M	$97M	$78M	$89M	$140M	$89M
Free Cash Flow (FCF)	$273M	$96M	$159M	$150M	$164M	$18M	$101M	$128M	$118M
FCF Margin %	25.6%	8.9%	15.5%	14.1%	15.5%	1.8%	10.5%	12.6%	11.8%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

COO Balance Sheet History

Balance sheet	2026-07-31	2025-10-31	2024-10-31	2023-10-31	2022-10-31	2021-10-31	2020-10-31	2019-10-31	2018-10-31	2017-10-31	2016-10-31	2015-10-31	2014-10-31	2013-10-31	2012-10-31	2011-10-31	2010-10-31	2009-10-31	2008-10-31	2007-10-31	2006-10-31
Total Assets	$12.7B	$12.4B	$12.3B	$11.7B	$11.5B	$9.6B	$6.7B	$6.3B	$6.1B	$4.9B	$4.5B	$4.5B	$4.5B	$3.1B	$2.9B	$2.6B	$2.5B	$2.6B	$2.6B	$2.6B	$2.4B
Cash & Cash Equivalents	$155M	$111M	$108M	$121M	$138M	$96M	$116M	$89M	$78M	$89M	$101M	$16M	$25M	$77M	$13M	$5M	$4M	$4M	$2M	$3M	$8M
Total Liabilities	$4.3B	$4.2B	$4.2B	$4.1B	$4.3B	$2.7B	$2.9B	$2.6B	$2.8B	$1.7B	$1.8B	$1.8B	$1.9B	$714M	$728M	$687M	$858M	$1.0B	$1.2B	$1.1B	$974M
Total Debt (Short + Long-Term)	$2.5B	$2.5B	$2.6B	$2.6B	$2.8B	$1.5B	$1.8B	$1.8B	$2.0B	$1.2B	$1.3B	$1.3B	$1.4B	$345M	$374M	$380M	$611M	$781M	$905M	$877M	$743M
Total Shareholders' Equity	$8.3B	$8.2B	$8.1B	$7.6B	$7.2B	$6.9B	$3.8B	$3.6B	$3.3B	$3.2B	$2.7B	$2.7B	$2.6B	$2.4B	$2.2B	$1.9B	$1.7B	$1.5B	$1.4B	$1.5B	$1.4B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive COO viewer.

COO Metric Deep Dives

Other Companies in Health Care Supplies

WST · West Pharmaceutical Services — $25 billion
ALGN · Align Technology — $10 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← CONY All “C” companies COOK →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.